Treatment Study for Obsessive-Compulsive Disorder

Sign-up now — Clinics in Philadelphia and New York City

•   Are you taking medication for obsessive-compulsive disorder?

      • Are you still having bothersome symptoms?

            • Are you interested in receiving no-cost treatment?

If you answered "yes" to all three questions, you may be eligible for treatment as part of a research program at the University of Pennsylvania and Columbia University.

Now Enrolling

No cost treatment is being offered for people who have obsessive-compulsive disorder (OCD) and are currently taking certain medications for their OCD but still have unwanted symptoms.

Treatments

Eligible participants will keep taking their OCD medication and be offered add-on treatment with medication, cognitive behavioral therapy (CBT), or a placebo pill, for approximately eight weeks. The goal of the project is to determine which treatment is most effective in helping people with OCD. Both the add-on medication and CBT have been shown to be effective in helping people with OCD.

Follow-Up Treatment

Individuals who improve will be invited to continue with the same treatment for six more months. Individuals who do not improve will be offered an additional 8.5 weeks of a different treatment (either the add-on medication or CBT).

Eligibility

Men and women ages 18-70 with OCD who are currently taking an SSRI medication (Prozac, Zoloft, Paxil, Luvox, and other similar medications) are eligible to participate in this study. There is no cost for the add-on medication or the cognitive-behavioral therapy.

Sponsorship

This study, funded by the National Institute of Mental Health, is a collaboration between Dr. Edna Foa from the University of Pennsylvania and Dr. Blair Simpson from Columbia University-New York State Psychiatric Institute. More...

Sign Up Now

For more information about participation or for a phone screening, contact us by phone or by email.